Track 1: Emerging Drug Targets

Session 1-1: GLP1R, GIPR

Session 1-2: GKAs, GPCR40

Session 1-3: OXM

Session 1-4: GPCR119

Session 1-5: GCGR

Session 1-6: PTP-1B

Session 1-7: FGF21

Session 1-8: PPARs

Track 2: Diabetes Drug Discovery Chemistry

Session 2-1: New Enabled Technologies for Drug Discovery

Session 2-2: Lead Compounds Discovery, Screening and Optimization

Session 2-3: Computer-aided Drug Design for Type 2 Diabetes

Session 2-4: ADME and PK/PD Studies in Drug Discovery

Session 2-5: Smart Drug Delivery and Formulation

Session 2-6: Traditional Medicine and Natural Products

Track 3: New Bioprocessing & Manufacturing

Session 3-1: Innovative Bioprocessing for Diabetes Drug Manufacturing    

Session 3-2: Novel Cell Lines, Cell Cultures and Purification Technologies

Session 3-3: New Biosimilars and Biobetters   

Session 3-4: Drug R&D Outsourcing and Integrative Services